v3.25.2
ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS - Divestiture of the Whole Blood Product Line and Strategic Investments (Details)
$ in Thousands, € in Millions
3 Months Ended
Jan. 13, 2025
USD ($)
Jun. 28, 2025
USD ($)
Dec. 28, 2024
USD ($)
Jun. 29, 2024
USD ($)
Jun. 28, 2025
EUR (€)
Mar. 29, 2025
USD ($)
Mar. 29, 2025
EUR (€)
Schedule of Investments [Line Items]              
Inventories, net   $ (360,527)       $ (365,141)  
Property, plant and equipment, net   (286,865)       (284,052)  
Payment to acquire investment   12,900   $ 12,900      
Gain (loss) on investments   0   $ 0      
Vivasure Medical LTD              
Schedule of Investments [Line Items]              
Investment   $ 68,000     € 58.0 $ 48,700 € 45.0
Disposal Group, Held-for-Sale, Not Discontinued Operations | Whole Blood Business              
Schedule of Investments [Line Items]              
Proceeds from divestiture $ 43,300            
Contingent consideration from divestiture 22,500            
Disposal Group, Not Discontinued Operations | Whole Blood              
Schedule of Investments [Line Items]              
Proceeds from divestiture $ 43,300            
Revision of Prior Period, Reclassification, Adjustment              
Schedule of Investments [Line Items]              
Inventories, net     $ 26,400        
Property, plant and equipment, net     7,800        
Assets held for sale     $ 6,400